Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1995 Mar;73(3):208. doi: 10.1136/hrt.73.3.208

Is increased tissue ferritin a risk factor for atherosclerosis and ischaemic heart disease?

J F Koster 1, W Sluiter 1
PMCID: PMC483799  PMID: 7727177

Full text

PDF

Page 208

208

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ascherio A., Willett W. C., Rimm E. B., Giovannucci E. L., Stampfer M. J. Dietary iron intake and risk of coronary disease among men. Circulation. 1994 Mar;89(3):969–974. doi: 10.1161/01.cir.89.3.969. [DOI] [PubMed] [Google Scholar]
  2. Burt M. J., Halliday J. W., Powell L. W. Iron and coronary heart disease. BMJ. 1993 Sep 4;307(6904):575–576. doi: 10.1136/bmj.307.6904.575. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Magnusson M. K., Sigfusson N., Sigvaldason H., Johannesson G. M., Magnusson S., Thorgeirsson G. Low iron-binding capacity as a risk factor for myocardial infarction. Circulation. 1994 Jan;89(1):102–108. doi: 10.1161/01.cir.89.1.102. [DOI] [PubMed] [Google Scholar]
  4. Nohl H., Stolze K., Napetschnig S., Ishikawa T. Is oxidative stress primarily involved in reperfusion injury of the ischemic heart? Free Radic Biol Med. 1991;11(6):581–588. doi: 10.1016/0891-5849(91)90139-t. [DOI] [PubMed] [Google Scholar]
  5. Sempos C. T., Looker A. C., Gillum R. F., Makuc D. M. Body iron stores and the risk of coronary heart disease. N Engl J Med. 1994 Apr 21;330(16):1119–1124. doi: 10.1056/NEJM199404213301604. [DOI] [PubMed] [Google Scholar]
  6. Sullivan J. L. Iron and coronary heart disease. Iron makes myocardium vulnerable to ischemia. BMJ. 1993 Oct 23;307(6911):1066–1067. doi: 10.1136/bmj.307.6911.1066-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Voogd A., Sluiter W., van Eijk H. G., Koster J. F. Low molecular weight iron and the oxygen paradox in isolated rat hearts. J Clin Invest. 1992 Nov;90(5):2050–2055. doi: 10.1172/JCI116086. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Williams R. E., Zweier J. L., Flaherty J. T. Treatment with deferoxamine during ischemia improves functional and metabolic recovery and reduces reperfusion-induced oxygen radical generation in rabbit hearts. Circulation. 1991 Mar;83(3):1006–1014. doi: 10.1161/01.cir.83.3.1006. [DOI] [PubMed] [Google Scholar]
  9. Wiltink W. F., Kruithof J., Mol C., Bos M. G., van Eijk H. G. Diurnal and nocturnal variations of the serum iron in normal subjects. Clin Chim Acta. 1973 Nov 23;49(1):99–104. doi: 10.1016/0009-8981(73)90348-3. [DOI] [PubMed] [Google Scholar]
  10. van der Kraaij A. M., Mostert L. J., van Eijk H. G., Koster J. F. Iron-load increases the susceptibility of rat hearts to oxygen reperfusion damage. Protection by the antioxidant (+)-cyanidanol-3 and deferoxamine. Circulation. 1988 Aug;78(2):442–449. doi: 10.1161/01.cir.78.2.442. [DOI] [PubMed] [Google Scholar]
  11. van der Kraaij A. M., van Eijk H. G., Koster J. F. Prevention of postischemic cardiac injury by the orally active iron chelator 1,2-dimethyl-3-hydroxy-4-pyridone (L1) and the antioxidant (+)-cyanidanol-3. Circulation. 1989 Jul;80(1):158–164. doi: 10.1161/01.cir.80.1.158. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES